Lipid metabolism and production of incretins in patients with obesity and type 2 diabetes mellitus after biliopancreatic diversion in Hess-Marceau modification at the early stages of follow-up

Lipid metabolism and production of incretins in patients with obesity and type 2 diabetes mellitus after biliopancreatic diversion in Hess-Marceau modification at the early stages of follow-up

Objectives: To study the lipid metabolism and secretion of GLP-1 and GIP in obese patients with type 2 diabetes before and 3 months after biliopancreatic diversion (BPD) in Hess-Marceau modification.Materials and methods: 22 patients (44 [38.0; 55.0] years) with morbid obesity (BMI of 50.1 [41.3; 53...

Full description

Bibliographic Details
Main Authors:	Ekaterina Ershova, Ekaterina Troshina, Yury Yashkov
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2016-11-01
Series:	Ожирение и метаболизм
Subjects:	obesity diabetes mellitus biliopancreatic diversion incretins
Online Access:	https://www.omet-endojournals.ru/jour/article/view/7846

Similar Items

Glucose metabolism and production of incretins in patients with obesity and type 2 diabetes mellitus after Biliopancreatic bypass surgery in the modification of Hess-Marceau the early stages of postoperative monitoring
by: Ivan Ivanovich Dedov, et al.
Published: (2015-04-01)

Incretin secretion and glucose metabolism in morbidly obese patients in the early and late periods after biliopancreatic diversion
by: I I Dedov, et al.
Published: (2016-10-01)

Hypoglycemia episodes after biliopancreatic diversion for morbid obesity: clinical case presentation
Published: (2013-10-01)

Evolution of biliopancreatic diversion in the treatment of morbid obesity and type 2 diabetes mellitus
by: Natalya S. Bordan, et al.
Published: (2017-08-01)

Glucose metabolism and incretins level in morbidly obese patients and in patients after biliopancreatic diversion performed for morbid obesity
Published: (2014-03-01)

Characteristics of carbohydrate metabolism in the surgical treatment of morbid obesity and type 2 diabetes mellitus using various modifications of biliopancreatic diversion with duodenal switch
by: V. M. Anohina, et al.
Published: (2022-10-01)

Metabolic and cardiovascular improvements after biliopancreatic diversion in a severely obese patient
by: Lescelleur Odette, et al.
Published: (2004-04-01)

A 7-year experience with the surgery of biliopancreatic diversion in the modification of Hess-Marceau for the treatment of morbid obesity and type 2 diabetes
Published: (2012-06-01)

Correction of metabolic syndrome and liver disease after biliopancreatic diversion in morbidly obese patients
Published: (2012-03-01)

First study on the outcomes of biliopancreatic diversion with duodenal switch in Chinese patients with obesity
by: Lun Wang, et al.
Published: (2023-01-01)

Biliopancreatic Endoscopy in Altered Anatomy
by: Ilaria Tarantino, et al.
Published: (2021-09-01)

Antibiotic Prophylaxis for Hepato-Biliopancreatic Surgery—A Systematic Review
by: Francesca Steccanella, et al.
Published: (2022-02-01)

Effect of biliopancreatic diversion on sleep quality and daytime sleepiness in patients with obesity and type 2 diabetes
by: Mayra Mello, et al.

Liver failure following biliopancreatic diversions: a narrative review
by: Everton Cazzo, et al.

Late complications of biliopancreatic diversion in an older patient: a case report
by: Nele Steenackers, et al.
Published: (2021-11-01)

Glycemia normalization in patients with obesity and type 2 diabetes mellitus: bariatric surgery vs pharmacological therapy
by: I A Sklyanik, et al.
Published: (2019-10-01)

Allele a of the rs16147 variant of neuropeptide Y predicts early metabolic improvements after bariatric surgery with biliopancreatic diversion in morbid obese subjects
by: David Pacheco, et al.
Published: (2021-04-01)

Innovations in the treatment of type 2 diabetes mellitus: use of incretins
by: Ivan Ivanovich Dedov, et al.
Published: (2010-10-01)

Pleiotropic effects of incretins
by: Vishal Gupta
Published: (2012-01-01)

BEYOND GLYCEMIC CONTROL IN DIABETES MELLITUS: EFFECTS OF INCRETIN-BASED THERAPY ON BONE METABOLISM
by: ELENA eCECCARELLI, et al.
Published: (2013-06-01)

Short versus long biliopancreatic limb in Roux-en-Y gastric bypass surgery for treatment of type 2 diabetes mellitus
by: Zhigang Ke, et al.
Published: (2020-10-01)

Comparison of one anastomosis gastric bypass versus standard Roux-en-Y gastric bypass versus a variant of biliopancreatic diversion, in a case-matched, non-superobese population: 6 years of follow-up
by: George Markopoulos, et al.
Published: (2021-08-01)

Biliopancreatic bypass with longitudinal gastrectomy and piloric preservation ("Duoderal Switch")
by: Hilton Telles Libanori
Published: (2006-03-01)

Incretins in patients with rheumatoid arthritis
by: Beatriz Tejera-Segura, et al.
Published: (2017-10-01)

The effect of oral essential amino acids on incretin hormone production in youth and ageing
by: Haitham Abdulla, et al.
Published: (2019-10-01)

The associations of incretin hormone concentration with gestational diabetes mellitus
by: Tatiana V. Saprina, et al.
Published: (2016-05-01)

New glance at pathogenesis of type 2 diabetes mellitus: incretin and antiincretin systems.
by: Ekaterina Alekseevna Shestakova
Published: (2011-09-01)

Incretin hormones as immunomodulators of atherosclerosis
by: Nuria eAlonso, et al.
Published: (2012-09-01)

The catcher in the gut: Tirzepatide, a dual incretin analog for the treatment of type 2 diabetes mellitus and obesity
by: Ioannis G. Lempesis, et al.
Published: (2022-12-01)

Models for Incretin Research: From the Intestine to the Whole Body
by: Tae Jung Oh
Published: (2016-03-01)

Weight loss after one-anastomosis/mini-gastric bypass – The impact of biliopancreatic limb: A retrospective cohort study
by: Mohammad Kermansaravi, et al.
Published: (2020-01-01)

Endoscopic ultrasound-guided biliary rendezvous after failed cannulation, and comparison between benign vs malignant biliopancreatic disorders: outcomes at a single tertiary-care centre
by: Joan B. Gornals, et al.
Published: (2024-12-01)

Tumor‐like features of gene expression and metabolic profiles in enlarged pancreatic islets are associated with impaired incretin‐induced insulin secretion in obese diabetes: A study of Zucker fatty diabetes mellitus rat
by: Tomohide Hayami, et al.
Published: (2020-11-01)

Features of carbohydrate metabolism and incretin secretion in patients with Cushing disease and acromegaly
by: Lubov V. Matchekhina, et al.
Published: (2017-10-01)

Effects of meal and incretins in the regulation of splanchnic blood flow
by: Jukka Koffert, et al.
Published: (2017-04-01)

The role of incretins in gestational diabetes: a case-control study on the impact of obesity
by: Engin Yurtcu, et al.
Published: (2024-10-01)

Revisiting the concept of incretin and enteroendocrine L-cells as type 2 diabetes mellitus treatment
by: Kok-Hou Lok, et al.
Published: (2022-06-01)

Incretins and their influence on the course of type 2 diabetes in patients with morbid obesity after bariatric oper
Published: (2012-06-01)

Understanding the Cardiovascular Effects of Incretin
by: Ji Sung Yoon, et al.
Published: (2011-10-01)

Recent clinical and pharmacological advancements of incretin-based therapy and the effects of incretin on physiology
by: Bhaskar Pal, et al.
Published: (2024-01-01)